EP0753528A4 - Prostaglandin i 2? receptor - Google Patents

Prostaglandin i 2? receptor

Info

Publication number
EP0753528A4
EP0753528A4 EP95907861A EP95907861A EP0753528A4 EP 0753528 A4 EP0753528 A4 EP 0753528A4 EP 95907861 A EP95907861 A EP 95907861A EP 95907861 A EP95907861 A EP 95907861A EP 0753528 A4 EP0753528 A4 EP 0753528A4
Authority
EP
European Patent Office
Prior art keywords
prostaglandin
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95907861A
Other languages
German (de)
French (fr)
Other versions
EP0753528A1 (en
Inventor
Atsushi Ichikawa
Kazuwa Nakao
Shuh Narumiya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of EP0753528A1 publication Critical patent/EP0753528A1/en
Publication of EP0753528A4 publication Critical patent/EP0753528A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP95907861A 1994-02-10 1995-02-08 Prostaglandin i 2? receptor Withdrawn EP0753528A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3770394 1994-02-10
JP37703/94 1994-02-10
PCT/JP1995/000175 WO1995021863A1 (en) 1994-02-10 1995-02-08 Prostaglandin i2 receptor

Publications (2)

Publication Number Publication Date
EP0753528A1 EP0753528A1 (en) 1997-01-15
EP0753528A4 true EP0753528A4 (en) 1999-03-10

Family

ID=12504895

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95907861A Withdrawn EP0753528A4 (en) 1994-02-10 1995-02-08 Prostaglandin i 2? receptor

Country Status (5)

Country Link
EP (1) EP0753528A4 (en)
JP (1) JP3692536B2 (en)
CN (1) CN1145076A (en)
CA (1) CA2183063A1 (en)
WO (1) WO1995021863A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6335459B1 (en) 1998-12-23 2002-01-01 Syntex (U.S.A.) Llc Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulators
HUE031710T2 (en) 2010-07-14 2017-07-28 Novartis Ag Ip receptor agonist heterocyclic compounds
WO2013105057A1 (en) 2012-01-13 2013-07-18 Novartis Ag Fused pyrroles as ip receptor agonists for the treatment of pulmonary arterial hypertension (pah) and related disorders
WO2014125413A1 (en) 2013-02-13 2014-08-21 Novartis Ag Ip receptor agonist heterocyclic compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009872A1 (en) * 1993-10-06 1995-04-13 Merck Frosst Canada Inc. Dna encoding prostaglandin receptor ip

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3508865B2 (en) * 1992-02-24 2004-03-22 周 成宮 Prostaglandin E receptor protein, DNA encoding the same and method for producing the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009872A1 (en) * 1993-10-06 1995-04-13 Merck Frosst Canada Inc. Dna encoding prostaglandin receptor ip

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL - EMHUM1 22 December 1993 (1993-12-22), KATSUYAMA, M. ET AL.: "Human mRNA for prostacyclin receptor, complete cds.", XP002087956 *
DATABASE INSIDE CONFERENCES XP002087957 *
GOUREAU, O. ET AL.: "Diverse prostaglandin receptors activate distinct signal transduction pathways in rat myometrium.", AMERICAN JOURNAL OF PHYSIOLOGY, vol. 32, no. 1, July 1992 (1992-07-01), pages C257 - C265, XP002087954 *
HIRATA, M. ET AL.: "Prostaglandin I receptor and prostaglandin D receptor.", JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, vol. 12, no. 2/3, February 1995 (1995-02-01), pages 393 - 404, XP002087955 *
KAJIKAWA, N. ET AL.: "Specific binding of the new stable epoprostenol analogue beraprost sodium to prostacyclin receptors on human and rat platelets.", ARZENEIMITTEL-FORSCHUNG/DRUG RESEARCH, vol. 39, no. 1, 1989, pages 495 - 9, XP002087953 *
KATSUYAMA, M. ET AL.: "Cloning and expression of a cDNA for the human prostacyclin receptor.", FEBS LETTERS, vol. 344, no. 1, 9 May 1994 (1994-05-09), pages 74 - 8, XP002087952 *
MOLECULAR BIOLOGY OF THE ARACHIDONATE CASCADE - INTERNATIONAL SYMPOSIUM, December 1993 (1993-12-01), Kyoto, Japan *
See also references of WO9521863A1 *

Also Published As

Publication number Publication date
WO1995021863A1 (en) 1995-08-17
EP0753528A1 (en) 1997-01-15
JP3692536B2 (en) 2005-09-07
CN1145076A (en) 1997-03-12
CA2183063A1 (en) 1995-08-17

Similar Documents

Publication Publication Date Title
IL119078A0 (en) Substituted benzylaminopiperidine compounds
AP9701021A0 (en) Novel compounds
EP0802908A4 (en) Novel compounds
HU9600255D0 (en) New compounds
GB9507203D0 (en) Novel compounds
GB9517098D0 (en) Receptor
GB9518692D0 (en) 'Spraymate'
GB9505538D0 (en) New compounds
GB9519997D0 (en) Saddle 3
EP0753528A4 (en) Prostaglandin i 2? receptor
GB9508453D0 (en) Type 120
GB9503717D0 (en) Novel compounds
PL320747A1 (en) Novel receptor
EP0862626A4 (en) Pilosulin 2
GB9403561D0 (en) Novel receptor
GB9513598D0 (en) Skite 2
TW344952U (en) Improved structure for connecting-ring
AU124802S (en) Cornice
AU124803S (en) Cornice
PL103387U1 (en) Cornice
PL103388U1 (en) Cornice
GB9407210D0 (en) As 350/355 helecopter nose-bracket
GB9503612D0 (en) Novel compounds
GB9502051D0 (en) Novel compounds
GB9502052D0 (en) Novel compounds

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19990121

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19980901